REQUEST A DEMO
Total
USD $0.00
Search more companies

Avesta Farmacevtika OOO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Avesta Farmacevtika OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Avesta Farmacevtika OOO is an enterprise in Russia, with the main office in Moscow. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Avesta Farmacevtika OOO was incorporated on June 04, 2004. The total number of employees is currently 18 (2009). There was a net sales revenue drop of 2.75% reported in Avesta Farmacevtika OOO’s latest financial highlights for 2023. A growth of 8.68% was recorded in its total assets. The net profit margin of Avesta Farmacevtika OOO decreased by 0.07% in 2023.

Headquarters
Varshavskoe, 33
Moscow; Moscow; Postal Code: 117105

Contact Details: Purchase the Avesta Farmacevtika OOO report to view the information.

Website: http://betasan.ru

Basic Information
Total Employees:
Purchase the Avesta Farmacevtika OOO report to view the information.
Outstanding Shares:
Purchase the Avesta Farmacevtika OOO report to view the information.
Registered Capital:
Purchase the Avesta Farmacevtika OOO report to view the information.
Incorporation Date:
June 04, 2004
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Rafarm OOO
90%
Company Performance
Financial values in the chart are available after Avesta Farmacevtika OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-2.75%
Total operating revenue
-2.75%
Operating profit (EBIT)
-1.74%
Net Profit (Loss) for the Period
-16.75%
Total assets
8.68%
Total equity
21.91%
Operating Profit Margin (ROS)
0.02%
Net Profit Margin
-0.07%
Return on Equity (ROE)
-8.34%
Debt to Equity Ratio
-48.1%
Quick Ratio
-0.03%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?